5.29
price down icon8.95%   -0.52
after-market 시간 외 거래: 5.30 0.010 +0.19%
loading
전일 마감가:
$5.81
열려 있는:
$5.495
하루 거래량:
17.89M
Relative Volume:
0.82
시가총액:
$2.73B
수익:
$64.60M
순이익/손실:
$-377.75M
주가수익비율:
-3.4129
EPS:
-1.55
순현금흐름:
$-335.64M
1주 성능:
-22.09%
1개월 성능:
-29.56%
6개월 성능:
-19.73%
1년 성능:
-46.94%
1일 변동 폭
Value
$5.19
$5.51
1주일 범위
Value
$5.19
$6.755
52주 변동 폭
Value
$5.19
$12.36

리커젼 파마 Stock (RXRX) Company Profile

Name
명칭
Recursion Pharmaceuticals Inc
Name
전화
(385) 269-0203
Name
주소
41S RIO GRANDE STREET, SALT LAKE CITY
Name
직원
0
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
RXRX's Discussions on Twitter

RXRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RXRX
Recursion Pharmaceuticals Inc
5.29 2.73B 64.60M -377.75M -335.64M -1.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

리커젼 파마 Stock (RXRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-05-22 개시 Morgan Stanley Equal-Weight
2023-03-16 개시 Needham Buy
2022-09-16 개시 KeyBanc Capital Markets Overweight
2022-04-18 다운그레이드 BofA Securities Buy → Neutral
2022-03-04 다운그레이드 SVB Leerink Outperform → Mkt Perform
2021-09-21 개시 Berenberg Buy
2021-05-11 개시 BofA Securities Buy
2021-05-11 개시 Goldman Neutral
2021-05-11 개시 JP Morgan Neutral
2021-05-11 개시 KeyBanc Capital Markets Overweight
2021-05-11 개시 SVB Leerink Outperform
모두보기

리커젼 파마 주식(RXRX)의 최신 뉴스

pulisher
03:25 AM

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today - Yahoo Finance

03:25 AM
pulisher
09:59 AM

Recursion stock hits 52-week low at $5.5 amid market challenges - Investing.com

09:59 AM
pulisher
Mar 30, 2025

Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? - The Motley Fool

Mar 30, 2025
pulisher
Mar 29, 2025

Recursion Pharmaceuticals CEO sells $836,986 in stock By Investing.com - Investing.com Australia

Mar 29, 2025
pulisher
Mar 28, 2025

Recursion Pharmaceuticals CEO sells $836,986 in stock - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Why Recursion Pharmaceuticals Inc. (RXRX) Performed Worst On Tuesday? - MSN

Mar 28, 2025
pulisher
Mar 27, 2025

Recursion: A Look At Near-Term Phase 1b And Phase 2 Catalysts (NASDAQ:RXRX) - Seeking Alpha

Mar 27, 2025
pulisher
Mar 27, 2025

(RXRX) Investment Report - Stock Traders Daily

Mar 27, 2025
pulisher
Mar 26, 2025

Is Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) the Best AI Stock to Invest in According to Reddit? - Insider Monkey

Mar 26, 2025
pulisher
Mar 24, 2025

12 Best AI Stocks to Invest in According to Reddit - Insider Monkey

Mar 24, 2025
pulisher
Mar 21, 2025

Why Recursion Pharmaceuticals (RXRX) Went Up on Monday? - MSN

Mar 21, 2025
pulisher
Mar 20, 2025

Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today - Yahoo Finance

Mar 20, 2025
pulisher
Mar 18, 2025

RXRX Quantitative Stock AnalysisBenjamin Graham - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Recursion Pharmaceuticals (NasdaqGS:RXRX) Jumps 12% Following US$500M Equity Offering - Yahoo Finance

Mar 18, 2025
pulisher
Mar 18, 2025

Recursion Pharma Down 37% in a Month: Buy, Sell or Hold the Stock? - Zacks Investment Research

Mar 18, 2025
pulisher
Mar 18, 2025

Recursion Pharmaceuticals Strengthens Board with New Appointments - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun - Yahoo Finance

Mar 18, 2025
pulisher
Mar 18, 2025

These 10 biotech companies are changing how we discover new drugs and treat complex diseases - Fast Company

Mar 18, 2025
pulisher
Mar 17, 2025

Recursion Pharmaceuticals's Options: A Look at What the Big Money is Thinking - Benzinga

Mar 17, 2025
pulisher
Mar 14, 2025

Jones Financial Companies Lllp Has $229,000 Position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - AOL

Mar 13, 2025
pulisher
Mar 13, 2025

HAYA Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer - Business Wire

Mar 13, 2025
pulisher
Mar 13, 2025

Proficio Capital Partners LLC Makes New $163,000 Investment in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Recursion Pharmaceuticals: Stretched Thin And Chasing Unicorns - Seeking Alpha

Mar 12, 2025
pulisher
Mar 12, 2025

Jim Cramer on Recursion Pharmaceuticals, Inc. (RXRX): ‘We’re Going To Have To Hold Off’ - Insider Monkey

Mar 12, 2025
pulisher
Mar 10, 2025

Recursion Pharma Gets A Price-Target Cut After Q4 Miss: Retail Bearish Even As Cathie Wood's Ark Buys The Dip - MSN

Mar 10, 2025
pulisher
Mar 10, 2025

Why Recursion Pharmaceuticals Stock Is Sinking Today - Yahoo Finance

Mar 10, 2025
pulisher
Mar 09, 2025

Jim Cramer’s Latest Lightning Round: 8 Stocks in Focus - Insider Monkey

Mar 09, 2025
pulisher
Mar 08, 2025

Is This Beaten-Down Artificial Intelligence (AI) Stock a Buy? - Nasdaq

Mar 08, 2025
pulisher
Mar 08, 2025

Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga

Mar 08, 2025
pulisher
Mar 08, 2025

QRG Capital Management Inc. Grows Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

This Is What Whales Are Betting On Recursion Pharmaceuticals - Benzinga

Mar 07, 2025
pulisher
Mar 07, 2025

Private Advisor Group LLC Increases Stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

4 Things You Need to Know if You Buy Recursion Pharmaceuticals Stock Today - MSN

Mar 07, 2025
pulisher
Mar 07, 2025

This Biotech Stock Could Be the Best Investment of the Decade - The Globe and Mail

Mar 07, 2025
pulisher
Mar 06, 2025

April 25th Options Now Available For Recursion Pharmaceuticals (RXRX) - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

Down Over 40%, Is Recursion Pharmaceuticals a Buy on the Dip? - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

IFP Advisors Inc Acquires 7,455 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Recursion Pharmaceuticals (RXRX) Remains Optimistic Despite Q4 Disappointment - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

TechBio Latest News - substack.com

Mar 06, 2025
pulisher
Mar 05, 2025

How To Trade (RXRX) - Stock Traders Daily

Mar 05, 2025
pulisher
Mar 05, 2025

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2024 Earnings Call Transcript - MSN

Mar 05, 2025

리커젼 파마 (RXRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
자본화:     |  볼륨(24시간):